Genelux Common Stock Today
| GNLX Stock | 5.34 0.12 2.20% |
PerformanceSolid
| Odds Of DistressLow
|
Genelux Common is trading at 5.34 as of the 16th of February 2025; that is 2.2 percent decrease since the beginning of the trading day. The stock's open price was 5.46. Genelux Common has less than a 18 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 17th of January 2025 and ending today, the 16th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 26th of January 2023 | Category Healthcare | Classification Health Care |
Genelux Common is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 34.54 M outstanding shares of which 1.87 M shares are currently shorted by private and institutional investors with about 7.02 trading days to cover. More on Genelux Common
Moving together with Genelux Stock
Moving against Genelux Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Genelux Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Chairman | Thomas JD | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsGenelux Common can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Genelux Common's financial leverage. It provides some insight into what part of Genelux Common's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genelux Common (GNLX) is traded on NASDAQ Exchange in USA. It is located in 2625 Townsgate Road, Westlake Village, CA, United States, 91361 and employs 25 people. Genelux Common is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 184.43 M. Genelux Common conducts business under Biotechnology sector and is part of Health Care industry. The entity has 34.54 M outstanding shares of which 1.87 M shares are currently shorted by private and institutional investors with about 7.02 trading days to cover.
Genelux Common generates negative cash flow from operations
Check Genelux Common Probability Of Bankruptcy
Ownership AllocationGenelux Common has a total of 34.54 Million outstanding shares. Genelux Common retains 16.63 (percent) of its outstanding shares held by insiders and 14.16 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Genelux Ownership Details
Genelux Common Historical Income Statement
Genelux Stock Against Markets
Genelux Common Corporate Management
| Caroline Jewett | VP Quality | Profile | |
| Ralph BSc | Head Affairs | Profile | |
| Sean JD | General Secretary | Profile | |
| Lourie Zak | Chief Officer | Profile | |
| Joseph Cappello | Chief Officer | Profile |
Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.